Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors
In our previous works, we have demonstrated that terfenadine (TEF) induces DNA damage and apoptosis in human melanoma cell lines. In this present work, we have studied the effect of histamine on viability of A375 human melanoma cells and the cell-signalling pathways through which TEF may induce its...
Gespeichert in:
Veröffentlicht in: | Carcinogenesis (New York) 2008-03, Vol.29 (3), p.500-509 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 509 |
---|---|
container_issue | 3 |
container_start_page | 500 |
container_title | Carcinogenesis (New York) |
container_volume | 29 |
creator | Jangi, Shawkat-Muhialdin Ruiz-Larrea, M.Begoña Nicolau-Galmés, Francesca Andollo, Noelia Arroyo-Berdugo, Yoana Ortega-Martínez, Idoia Díaz-Pérez, José Luís Boyano, María D. |
description | In our previous works, we have demonstrated that terfenadine (TEF) induces DNA damage and apoptosis in human melanoma cell lines. In this present work, we have studied the effect of histamine on viability of A375 human melanoma cells and the cell-signalling pathways through which TEF may induce its apoptotic effect. We have found that exogenous histamine stimulates A375 melanoma cell proliferation in a dose- and time-dependent manner. Moreover, TEF-induced apoptosis seems to occur via other cellular pathways independent of the histamine-signalling system since co-treatment of histamine with TEF did not protect melanoma cells from the cytotoxic effect of TEF, and alpha fluoromethylhistidine did not induce the same cytotoxic effect of TEF. In addition, we have observed that knocking down the H1 histamine receptor (HRH1) by small interference RNA approach protects melanoma cells only slightly from TEF-induced apoptosis. To explore the molecular mechanisms responsible for histamine and TEF effect on the cell growth, we analysed intracellular cyclic nucleotides and Ca2+ levels. TEF did not modify intracellular levels of cyclic adenosine 3′,5′-monophosphate and cyclic guanine 3′,5′-monophosphate; however, TEF induced a very sharp and sustained increase in cytosolic Ca2+ levels in A375 melanoma cells. On the contrary, histamine did not modulate intracellular Ca2+. TEF-induced Ca2+ rise and apoptosis appear to be phospholipase C (PLC) dependent since neomycin and U73122, two inhibitors of PLC, abolished cytosolic Ca2+ increase and protected the cells completely from cell death. Furthermore, inhibition of tyrosine kinase activity by genistein blocked cytosolic Ca2+ rise and TEF-induced apoptosis. These results suggest that TEF modulates Ca2+ homeostasis and induces apoptosis through other cellular pathways involving tyrosine kinase activity, independently of HRH1. |
doi_str_mv | 10.1093/carcin/bgm292 |
format | Article |
fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_carcin_bgm292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/carcin/bgm292</oup_id><sourcerecordid>10.1093/carcin/bgm292</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-993a2d2575f172188fd00939ce15eda15af0f04f33560413db2bdf8e47ae991c3</originalsourceid><addsrcrecordid>eNqFkEuLFDEURoMoTju6dCvZCIKWk0elHktpHy0MOGAL4qa4ndxMxalKiqRK7N_knzRNNePSTQKXc7_7cQh5ztlbzlp5pSFq568Ot6NoxQOy4WXFCsEb9pBsGC9lIaUsL8iTlH4yxiup2sfkgje8LoVsN-TPHqNFD8Z5LJw3i0ZDYQrTHJJL1HnaLyN4OuIAPoxANQ5Dnqc8MQ7mTM99DMttT7cgXtM-jBjSDKflMZhlgNkFT8Fn7hhzpkd65zwkpKBn98vNxzf5isEJ8-Pn4UiDpTtOe5dTxhMeUWOuE9NT8sjCkPDZ-b8k3z5-2G93xfWXT5-3764LXYp6LtpWgjBC1cryOptorGHZVKuRKzTAFVhmWWmlVBUruTQHcTC2wbIGbFuu5SUp1lydC6eItpuiGyEeO866k_Ruld6t0jP_YuWn5ZCt_KPPljPw8gxA0jDYCF67dM8JlltWqs7cq5ULy_Tfm-eOWRP-voch3nVVLWvV7b7_6NTNzf5r3fDuvfwLoJetlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Jangi, Shawkat-Muhialdin ; Ruiz-Larrea, M.Begoña ; Nicolau-Galmés, Francesca ; Andollo, Noelia ; Arroyo-Berdugo, Yoana ; Ortega-Martínez, Idoia ; Díaz-Pérez, José Luís ; Boyano, María D.</creator><creatorcontrib>Jangi, Shawkat-Muhialdin ; Ruiz-Larrea, M.Begoña ; Nicolau-Galmés, Francesca ; Andollo, Noelia ; Arroyo-Berdugo, Yoana ; Ortega-Martínez, Idoia ; Díaz-Pérez, José Luís ; Boyano, María D.</creatorcontrib><description>In our previous works, we have demonstrated that terfenadine (TEF) induces DNA damage and apoptosis in human melanoma cell lines. In this present work, we have studied the effect of histamine on viability of A375 human melanoma cells and the cell-signalling pathways through which TEF may induce its apoptotic effect. We have found that exogenous histamine stimulates A375 melanoma cell proliferation in a dose- and time-dependent manner. Moreover, TEF-induced apoptosis seems to occur via other cellular pathways independent of the histamine-signalling system since co-treatment of histamine with TEF did not protect melanoma cells from the cytotoxic effect of TEF, and alpha fluoromethylhistidine did not induce the same cytotoxic effect of TEF. In addition, we have observed that knocking down the H1 histamine receptor (HRH1) by small interference RNA approach protects melanoma cells only slightly from TEF-induced apoptosis. To explore the molecular mechanisms responsible for histamine and TEF effect on the cell growth, we analysed intracellular cyclic nucleotides and Ca2+ levels. TEF did not modify intracellular levels of cyclic adenosine 3′,5′-monophosphate and cyclic guanine 3′,5′-monophosphate; however, TEF induced a very sharp and sustained increase in cytosolic Ca2+ levels in A375 melanoma cells. On the contrary, histamine did not modulate intracellular Ca2+. TEF-induced Ca2+ rise and apoptosis appear to be phospholipase C (PLC) dependent since neomycin and U73122, two inhibitors of PLC, abolished cytosolic Ca2+ increase and protected the cells completely from cell death. Furthermore, inhibition of tyrosine kinase activity by genistein blocked cytosolic Ca2+ rise and TEF-induced apoptosis. These results suggest that TEF modulates Ca2+ homeostasis and induces apoptosis through other cellular pathways involving tyrosine kinase activity, independently of HRH1.</description><identifier>ISSN: 0143-3334</identifier><identifier>EISSN: 1460-2180</identifier><identifier>DOI: 10.1093/carcin/bgm292</identifier><identifier>PMID: 18174239</identifier><identifier>CODEN: CRNGDP</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Apoptosis - drug effects ; Base Sequence ; Biological and medical sciences ; Calcium - metabolism ; Carcinogenesis, carcinogens and anticarcinogens ; Cell Line, Tumor ; Cyclic AMP - metabolism ; Cyclic GMP - metabolism ; Dermatology ; DNA Primers ; Egtazic Acid - analogs & derivatives ; Egtazic Acid - pharmacology ; Electrophoresis, Polyacrylamide Gel ; Fluorescent Antibody Technique ; Histamine H1 Antagonists, Non-Sedating - pharmacology ; Homeostasis ; Humans ; Inositol Phosphates - metabolism ; Medical sciences ; Melanoma - enzymology ; Melanoma - metabolism ; Melanoma - pathology ; Protein-Tyrosine Kinases - metabolism ; Receptors, Histamine H1 - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Small Interfering ; Terfenadine - pharmacology ; Tumors ; Tumors of the skin and soft tissue. Premalignant lesions ; Type C Phospholipases - metabolism</subject><ispartof>Carcinogenesis (New York), 2008-03, Vol.29 (3), p.500-509</ispartof><rights>The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2008</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-993a2d2575f172188fd00939ce15eda15af0f04f33560413db2bdf8e47ae991c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1583,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20218657$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18174239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jangi, Shawkat-Muhialdin</creatorcontrib><creatorcontrib>Ruiz-Larrea, M.Begoña</creatorcontrib><creatorcontrib>Nicolau-Galmés, Francesca</creatorcontrib><creatorcontrib>Andollo, Noelia</creatorcontrib><creatorcontrib>Arroyo-Berdugo, Yoana</creatorcontrib><creatorcontrib>Ortega-Martínez, Idoia</creatorcontrib><creatorcontrib>Díaz-Pérez, José Luís</creatorcontrib><creatorcontrib>Boyano, María D.</creatorcontrib><title>Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors</title><title>Carcinogenesis (New York)</title><addtitle>Carcinogenesis</addtitle><description>In our previous works, we have demonstrated that terfenadine (TEF) induces DNA damage and apoptosis in human melanoma cell lines. In this present work, we have studied the effect of histamine on viability of A375 human melanoma cells and the cell-signalling pathways through which TEF may induce its apoptotic effect. We have found that exogenous histamine stimulates A375 melanoma cell proliferation in a dose- and time-dependent manner. Moreover, TEF-induced apoptosis seems to occur via other cellular pathways independent of the histamine-signalling system since co-treatment of histamine with TEF did not protect melanoma cells from the cytotoxic effect of TEF, and alpha fluoromethylhistidine did not induce the same cytotoxic effect of TEF. In addition, we have observed that knocking down the H1 histamine receptor (HRH1) by small interference RNA approach protects melanoma cells only slightly from TEF-induced apoptosis. To explore the molecular mechanisms responsible for histamine and TEF effect on the cell growth, we analysed intracellular cyclic nucleotides and Ca2+ levels. TEF did not modify intracellular levels of cyclic adenosine 3′,5′-monophosphate and cyclic guanine 3′,5′-monophosphate; however, TEF induced a very sharp and sustained increase in cytosolic Ca2+ levels in A375 melanoma cells. On the contrary, histamine did not modulate intracellular Ca2+. TEF-induced Ca2+ rise and apoptosis appear to be phospholipase C (PLC) dependent since neomycin and U73122, two inhibitors of PLC, abolished cytosolic Ca2+ increase and protected the cells completely from cell death. Furthermore, inhibition of tyrosine kinase activity by genistein blocked cytosolic Ca2+ rise and TEF-induced apoptosis. These results suggest that TEF modulates Ca2+ homeostasis and induces apoptosis through other cellular pathways involving tyrosine kinase activity, independently of HRH1.</description><subject>Apoptosis - drug effects</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Calcium - metabolism</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Cell Line, Tumor</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic GMP - metabolism</subject><subject>Dermatology</subject><subject>DNA Primers</subject><subject>Egtazic Acid - analogs & derivatives</subject><subject>Egtazic Acid - pharmacology</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Fluorescent Antibody Technique</subject><subject>Histamine H1 Antagonists, Non-Sedating - pharmacology</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Inositol Phosphates - metabolism</subject><subject>Medical sciences</subject><subject>Melanoma - enzymology</subject><subject>Melanoma - metabolism</subject><subject>Melanoma - pathology</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Receptors, Histamine H1 - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Small Interfering</subject><subject>Terfenadine - pharmacology</subject><subject>Tumors</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><subject>Type C Phospholipases - metabolism</subject><issn>0143-3334</issn><issn>1460-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEuLFDEURoMoTju6dCvZCIKWk0elHktpHy0MOGAL4qa4ndxMxalKiqRK7N_knzRNNePSTQKXc7_7cQh5ztlbzlp5pSFq568Ot6NoxQOy4WXFCsEb9pBsGC9lIaUsL8iTlH4yxiup2sfkgje8LoVsN-TPHqNFD8Z5LJw3i0ZDYQrTHJJL1HnaLyN4OuIAPoxANQ5Dnqc8MQ7mTM99DMttT7cgXtM-jBjSDKflMZhlgNkFT8Fn7hhzpkd65zwkpKBn98vNxzf5isEJ8-Pn4UiDpTtOe5dTxhMeUWOuE9NT8sjCkPDZ-b8k3z5-2G93xfWXT5-3764LXYp6LtpWgjBC1cryOptorGHZVKuRKzTAFVhmWWmlVBUruTQHcTC2wbIGbFuu5SUp1lydC6eItpuiGyEeO866k_Ruld6t0jP_YuWn5ZCt_KPPljPw8gxA0jDYCF67dM8JlltWqs7cq5ULy_Tfm-eOWRP-voch3nVVLWvV7b7_6NTNzf5r3fDuvfwLoJetlw</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Jangi, Shawkat-Muhialdin</creator><creator>Ruiz-Larrea, M.Begoña</creator><creator>Nicolau-Galmés, Francesca</creator><creator>Andollo, Noelia</creator><creator>Arroyo-Berdugo, Yoana</creator><creator>Ortega-Martínez, Idoia</creator><creator>Díaz-Pérez, José Luís</creator><creator>Boyano, María D.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080301</creationdate><title>Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors</title><author>Jangi, Shawkat-Muhialdin ; Ruiz-Larrea, M.Begoña ; Nicolau-Galmés, Francesca ; Andollo, Noelia ; Arroyo-Berdugo, Yoana ; Ortega-Martínez, Idoia ; Díaz-Pérez, José Luís ; Boyano, María D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-993a2d2575f172188fd00939ce15eda15af0f04f33560413db2bdf8e47ae991c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Apoptosis - drug effects</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Calcium - metabolism</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Cell Line, Tumor</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic GMP - metabolism</topic><topic>Dermatology</topic><topic>DNA Primers</topic><topic>Egtazic Acid - analogs & derivatives</topic><topic>Egtazic Acid - pharmacology</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Fluorescent Antibody Technique</topic><topic>Histamine H1 Antagonists, Non-Sedating - pharmacology</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Inositol Phosphates - metabolism</topic><topic>Medical sciences</topic><topic>Melanoma - enzymology</topic><topic>Melanoma - metabolism</topic><topic>Melanoma - pathology</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Receptors, Histamine H1 - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Small Interfering</topic><topic>Terfenadine - pharmacology</topic><topic>Tumors</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><topic>Type C Phospholipases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jangi, Shawkat-Muhialdin</creatorcontrib><creatorcontrib>Ruiz-Larrea, M.Begoña</creatorcontrib><creatorcontrib>Nicolau-Galmés, Francesca</creatorcontrib><creatorcontrib>Andollo, Noelia</creatorcontrib><creatorcontrib>Arroyo-Berdugo, Yoana</creatorcontrib><creatorcontrib>Ortega-Martínez, Idoia</creatorcontrib><creatorcontrib>Díaz-Pérez, José Luís</creatorcontrib><creatorcontrib>Boyano, María D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Carcinogenesis (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jangi, Shawkat-Muhialdin</au><au>Ruiz-Larrea, M.Begoña</au><au>Nicolau-Galmés, Francesca</au><au>Andollo, Noelia</au><au>Arroyo-Berdugo, Yoana</au><au>Ortega-Martínez, Idoia</au><au>Díaz-Pérez, José Luís</au><au>Boyano, María D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors</atitle><jtitle>Carcinogenesis (New York)</jtitle><addtitle>Carcinogenesis</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>29</volume><issue>3</issue><spage>500</spage><epage>509</epage><pages>500-509</pages><issn>0143-3334</issn><eissn>1460-2180</eissn><coden>CRNGDP</coden><abstract>In our previous works, we have demonstrated that terfenadine (TEF) induces DNA damage and apoptosis in human melanoma cell lines. In this present work, we have studied the effect of histamine on viability of A375 human melanoma cells and the cell-signalling pathways through which TEF may induce its apoptotic effect. We have found that exogenous histamine stimulates A375 melanoma cell proliferation in a dose- and time-dependent manner. Moreover, TEF-induced apoptosis seems to occur via other cellular pathways independent of the histamine-signalling system since co-treatment of histamine with TEF did not protect melanoma cells from the cytotoxic effect of TEF, and alpha fluoromethylhistidine did not induce the same cytotoxic effect of TEF. In addition, we have observed that knocking down the H1 histamine receptor (HRH1) by small interference RNA approach protects melanoma cells only slightly from TEF-induced apoptosis. To explore the molecular mechanisms responsible for histamine and TEF effect on the cell growth, we analysed intracellular cyclic nucleotides and Ca2+ levels. TEF did not modify intracellular levels of cyclic adenosine 3′,5′-monophosphate and cyclic guanine 3′,5′-monophosphate; however, TEF induced a very sharp and sustained increase in cytosolic Ca2+ levels in A375 melanoma cells. On the contrary, histamine did not modulate intracellular Ca2+. TEF-induced Ca2+ rise and apoptosis appear to be phospholipase C (PLC) dependent since neomycin and U73122, two inhibitors of PLC, abolished cytosolic Ca2+ increase and protected the cells completely from cell death. Furthermore, inhibition of tyrosine kinase activity by genistein blocked cytosolic Ca2+ rise and TEF-induced apoptosis. These results suggest that TEF modulates Ca2+ homeostasis and induces apoptosis through other cellular pathways involving tyrosine kinase activity, independently of HRH1.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18174239</pmid><doi>10.1093/carcin/bgm292</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0143-3334 |
ispartof | Carcinogenesis (New York), 2008-03, Vol.29 (3), p.500-509 |
issn | 0143-3334 1460-2180 |
language | eng |
recordid | cdi_crossref_primary_10_1093_carcin_bgm292 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
subjects | Apoptosis - drug effects Base Sequence Biological and medical sciences Calcium - metabolism Carcinogenesis, carcinogens and anticarcinogens Cell Line, Tumor Cyclic AMP - metabolism Cyclic GMP - metabolism Dermatology DNA Primers Egtazic Acid - analogs & derivatives Egtazic Acid - pharmacology Electrophoresis, Polyacrylamide Gel Fluorescent Antibody Technique Histamine H1 Antagonists, Non-Sedating - pharmacology Homeostasis Humans Inositol Phosphates - metabolism Medical sciences Melanoma - enzymology Melanoma - metabolism Melanoma - pathology Protein-Tyrosine Kinases - metabolism Receptors, Histamine H1 - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA, Small Interfering Terfenadine - pharmacology Tumors Tumors of the skin and soft tissue. Premalignant lesions Type C Phospholipases - metabolism |
title | Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A12%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Terfenadine-induced%20apoptosis%20in%20human%20melanoma%20cells%20is%20mediated%20through%20Ca2+%20homeostasis%20modulation%20and%20tyrosine%20kinase%20activity,%20independently%20of%20H1%20histamine%20receptors&rft.jtitle=Carcinogenesis%20(New%20York)&rft.au=Jangi,%20Shawkat-Muhialdin&rft.date=2008-03-01&rft.volume=29&rft.issue=3&rft.spage=500&rft.epage=509&rft.pages=500-509&rft.issn=0143-3334&rft.eissn=1460-2180&rft.coden=CRNGDP&rft_id=info:doi/10.1093/carcin/bgm292&rft_dat=%3Coup_cross%3E10.1093/carcin/bgm292%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18174239&rft_oup_id=10.1093/carcin/bgm292&rfr_iscdi=true |